Bayer (BAYN.DE) Aandeel Koers
Bayer Koers
In de afgelopen 19 jaar liet Bayer de omzet jaarlijks met 2,4% groeien tot 45,58 Miljard EUR. De winst per aandeel is de afgelopen 16 jaar met 6,5% per jaar gegroeid. Bij Bayer is de nettowinstmarge met -7,9% ten opzichte van 2,3% enkele jaren geleden gedaald. Op de huidige koers komt het dividendrendement uit op ongeveer 0,24%. Het consensus-koersdoel voor Bayer op 12 maanden bedraagt 41,92 EUR, circa 6,7% onder de huidige koers. Van de 29 analisten geven 17 het aandeel een koopadvies — per saldo een Kopen-consensus.
Bayer aandeelkoers
Bayer bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Bayer
The business model of Bayer AG is focused on the development, manufacturing, and sale of healthcare and agricultural products. As a global pharmaceutical and life sciences company, Bayer AG operates in various sectors such as Pharmaceuticals, Consumer Health, Crop Science, and Animal Health. With its innovative research and development, Bayer AG aims to improve people's lives through its products and solutions. By maintaining a diverse portfolio, strong market presence, and strategic partnerships, the company seeks to address global challenges and contribute to a sustainable future in the fields of healthcare and agriculture.
Bayer AG is primarily active in the pharmaceutical, consumer health, and agricultural industries.
The main competitors of Bayer AG in the market include companies like Johnson & Johnson, Novartis AG, and Sanofi. These companies are also prominent players in the healthcare and pharmaceutical sectors. Bayer AG, a leading life sciences company, competes with these global giants in the areas of pharmaceuticals, consumer health, and crop science. With its diversified portfolio and innovative solutions, Bayer AG strives to stay competitive and maintain market leadership in its various segments.
Bayer AG is a renowned German pharmaceutical and life sciences company with a rich history and strong background. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, Bayer initially focused on the production of synthetic dyes. Over time, it diversified its portfolio and entered the fields of healthcare, agriculture, and high-tech materials. Today, Bayer is globally recognized for its contributions to medicine, crop protection, and innovative materials. With a commitment to science and sustainability, Bayer continues to improve lives and address global challenges.
Bayer AG has achieved significant milestones throughout its history. Some notable achievements include the development of Aspirin, a widely recognized pain reliever, and the invention of the first oral contraceptive pill. The company also played a crucial role in introducing genetically modified crops, revolutionizing agriculture practices. Additionally, Bayer AG successfully completed the acquisition of Monsanto Company, a leading agricultural biotechnology company. With a rich history of innovation and successful business ventures, Bayer AG continues to make strides in the fields of healthcare, pharmaceuticals, and agriculture, solidifying its position as a global industry leader.
Bayer AG is primarily present in numerous countries and regions worldwide. As a global pharmaceutical and life sciences company, Bayer AG has established a strong presence across Europe, North America, Asia Pacific, and Latin America. Specifically, in Europe, the company has a significant presence in Germany, where its headquarters are located. Furthermore, Bayer AG has a substantial footprint in the United States, contributing to its strong presence in North America. The company's operations extend into key markets in China and other Asian countries as well. With its global reach, Bayer AG aims to serve patients and customers around the world with innovative solutions and products.
Bayer AG represents values of innovation, sustainability, and responsibility. As a global company, Bayer focuses on providing solutions that improve people's lives and contribute to societal progress. Their corporate philosophy emphasizes ethical behavior, fairness, and integrity in all business activities. Bayer is committed to scientific excellence and advances in areas such as healthcare, agriculture, and nutrition. They strive to create a more sustainable future by developing environmentally friendly products and reducing their ecological footprint. With a strong emphasis on research and development, Bayer AG aims to continuously drive growth and make a positive impact worldwide.
Analisten hanteren momenteel een gemiddeld koersdoel van 42,36 EUR voor het aandeel Bayer (mediaan: 41,92 EUR), oftewel -5,8 % ten opzichte van de laatste koers. De consensus is gebaseerd op 29 analistenratings.
29 analisten beoordelen het aandeel Bayer momenteel: 17 adviseren kopen, 10 houden en 2 verkopen. Voor 2026 verwachten analisten dat Bayer een omzet van 45,83 Miljard EUR en winst per aandeel van 4,53 EUR behaalt.
Het aandeel Bayer (BAYN.DE) is genoteerd aan 14 beurzen, waaronder: NASDAQ (BAYZF), London (0P6S.L), SIX (Zürich) (BAYN.SW), XETRA (BAYN.DE), Frankfurt (BAYN.F), München (BAYN.MU), Stuttgart (BAYN.SG), Düsseldorf (BAYN.DU).
The Bayer AG is a German company that operates in various business sectors. The company is active in the chemical and pharmaceutical industry and offers a wide range of products and services. Pharma and Health One of Bayer's most well-known business sectors is pharma and health. The company produces a variety of medications used for treating diseases such as diabetes, cancer, cardiovascular diseases, and many more. The most well-known medications include the pain reliever Aspirin, the contraceptive Yaz, and the cancer medication Nexavar. Crop Science Another important business sector of Bayer is Crop Science. Bayer produces seeds and plant protection products for the agribusiness sector. The company offers a wide range of products for the cultivation of crops such as grains, vegetables, and fruits. The company also supports farmers in the efficient use of water and energy for sustainable agriculture. Bayer Crop Science is a key player in the global agricultural landscape. Consumer Health Bayer also has a Consumer Health business sector that offers a variety of products for health and personal care. The company produces medications for minor illnesses and diseases such as cold and flu, as well as self-care products such as pain ointments, antiseptics, skin creams, and vitamins. The most well-known products include Coppertone sunscreen and the pain reliever Aleve. Animal Health Bayer also utilizes its expertise in animal health by producing medications and services. This business sector focuses on the health and well-being of livestock and pets. The company has an extensive range of products for the treatment and prevention of disease-related risks in pets as well as livestock. Bayer also has various business sectors focusing on the production of chemicals, materials, and technologies for the production of plastics, paints, adhesives, high-tech products, and more. Overall, Bayer AG's business model is oriented towards strong diversification to minimize risks and seize opportunities in various markets. With a wide range of products and a strong presence in different regions, Bayer continuously generates a high volume of revenue through its strong research and development and is an important company for the German economy.
De verwachte omzet van Bayer bedraagt 45,83 Miljard EUR. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De verwachte winst van Bayer bedraagt 4,45 Miljard EUR. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van Bayer bedraagt momenteel 9,92. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Bayer-aandeel in te schatten.
De koers-omzetverhouding (P/S) van Bayer bedraagt momenteel 0,96. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Bayer-aandeel.
De Eulerpool Kwaliteitsscore voor Bayer is 0/10.
De ISIN van Bayer is DE000BAY0017. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Bayer is BAY001. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Bayer is BAYN.DE. Onder dit beurstickersymbool wordt het Bayer-aandeel op de beurs verhandeld.
Bayer aandeel
Bayer Ticker
Bayer FIGI
Alle fundamentals en diepgaande analyse van Bayer
Onze aandelenanalyse van het Bayer-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Bayer. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: